Section 4: Clinical Pharmacy Services

4CPS-259

USEFULNESS OF CYSTATIN C AS A BIOMARKER OF RENAL FUNCTION IN DRUG DOSING IN A HAEMATOLOGIC PATIENT WITH PROTEIN MALNUTRITION

4CPS-255

EXPANDING THE PROCESS OF PHARMACEUTICAL CARE TO THE INSTITUTIONALISED PATIENT CARE UNIT

4CPS-254

MEDICATION REVIEW: CASE REPORT OF A FRAGILE PATIENT’S FALL

4CPS-253

LOCAL ASSESSMENT OF MEDICATION REVIEW IN AN INTERNAL MEDICINE UNIT

4CPS-252

EFFECTIVENESS OF SACRAL NEUROMODULATION IN TWO PATIENTS WITH TETHERED CORD SYNDROME OUTPUTS: A CASE REPORT

4CPS-245

IMPLEMENTING CLINICAL PHARMACY PRACTICES IN THE COMPREHENSIVE GERIATRIC ASSESSMENT PERFORMED BY THE MOBILE GERIATRIC MULTIDISCIPLINARY TEAM IN ORTHOPAEDIC UNITS

4CPS-242

INVOLVEMENT OF A PHARMACIST IN A GERIATRIC TEAM IN PRIMARY CARE

4CPS-240

ADDING VALUE: PHARMACIST INTERVENTIONS IN THE PERIOPERATIVE SETTING

4CPS-239

EVALUATION OF CLINICAL PHARMACIST INTERVENTIONS IN SURGICAL PATIENTS

4CPS-230

PROSPECTIVE STUDY TO EXPLORE THE IMPACT OF A CLINICAL PHARMACIST IN A CARDIAC SURGICAL POPULATION OR AFTER ACUTE CORONARY SYNDROME

4CPS-227

OBTAINING THE MOST ACCURATE LIST OF CURRENT MEDICATION FOR THE PATIENT

4CPS-222

DECREASED USE OF PIMS IN ELDERLY HOSPITALISED PATIENTS: IS IT POSSIBLE?

4CPS-220

CLINICAL PHARMACIST INTERVENTIONS IN HOSPITALISED PATIENTS WITH RENAL IMPAIRMENT

4CPS-218

ASSOCIATION BETWEEN ORAL SOLUTION OF 24% SUCROSE AND PROCEDURAL PAIN BY PRETERM INFANTS

4CPS-217

HEPATITIS B TREATMENT: TOWARDS EFFECTIVENESS AND ADHERENCE

Pages